Kaye FJ - Search Results

1

Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.

Kellish P, Shabashvili D, Rahman MM, Nawab A, Guijarro MV, Zhang M, Cao C, Moussatche N, Boyle T, Antonia S, Reinhard M, Hartzell C, Jantz M, Mehta HJ, McFadden G, Kaye FJ, Zajac-Kaye M. Kellish P, et al. Among authors: kaye fj. J Clin Invest. 2019 Apr 29;129(6):2279-2292. doi: 10.1172/JCI121323. eCollection 2019 Apr 29. J Clin Invest. 2019. PMID: 31033480 Free PMC article.

2

RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer.

Coxon AB, Ward JM, Geradts J, Otterson GA, Zajac-Kaye M, Kaye FJ. Coxon AB, et al. Among authors: kaye fj. Oncogene. 1998 Sep 24;17(12):1625-8. doi: 10.1038/sj.onc.1202381. Oncogene. 1998. PMID: 9794240

3

Evolutionary conservation of a 2-kb intronic sequence flanking a tissue-specific alternative exon in the PTBP2 gene.

Rahman L, Bliskovski V, Kaye FJ, Zajac-Kaye M. Rahman L, et al. Among authors: kaye fj. Genomics. 2004 Jan;83(1):76-84. doi: 10.1016/s0888-7543(03)00207-6. Genomics. 2004. PMID: 14667811

4

Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.

Rahman L, Voeller D, Rahman M, Lipkowitz S, Allegra C, Barrett JC, Kaye FJ, Zajac-Kaye M. Rahman L, et al. Among authors: kaye fj. Cancer Cell. 2004 Apr;5(4):341-51. doi: 10.1016/s1535-6108(04)00080-7. Cancer Cell. 2004. PMID: 15093541 Free article.

5

Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.

Chen M, Rahman L, Voeller D, Kastanos E, Yang SX, Feigenbaum L, Allegra C, Kaye FJ, Steeg P, Zajac-Kaye M. Chen M, et al. Among authors: kaye fj. Oncogene. 2007 Jul 19;26(33):4817-24. doi: 10.1038/sj.onc.1210273. Epub 2007 Feb 12. Oncogene. 2007. PMID: 17297449

6

Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer.

Komiya T, Coxon A, Park Y, Chen WD, Zajac-Kaye M, Meltzer P, Karpova T, Kaye FJ. Komiya T, et al. Among authors: kaye fj. Oncogene. 2010 Mar 18;29(11):1672-80. doi: 10.1038/onc.2009.453. Epub 2009 Dec 14. Oncogene. 2010. PMID: 20010869 Free PMC article.

7

Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.

Chen M, Voeller D, Marquez VE, Kaye FJ, Steeg PS, Giaccone G, Zajac-Kaye M. Chen M, et al. Among authors: kaye fj. Int J Oncol. 2010 Oct;37(4):963-71. doi: 10.3892/ijo_00000747. Int J Oncol. 2010. PMID: 20811718 Free PMC article.

8

Successful erlotinib rechallenge after erlotinib-induced interstitial lung disease.

Dallas JL, Jantz MA, Lightsey JL, Sonntag C, Kaye FJ. Dallas JL, et al. Among authors: kaye fj. J Thorac Oncol. 2011 Jun;6(6):1142-3. doi: 10.1097/JTO.0b013e318217b684. J Thorac Oncol. 2011. PMID: 21623280 Free article. No abstract available.

9

Erlotinib or gefitinib for non-small-cell lung cancer.

Kaye FJ, Jantz MA, Dallas J. Kaye FJ, et al. N Engl J Med. 2011 Jun 16;364(24):2367; author reply 2368. doi: 10.1056/NEJMc1103918. N Engl J Med. 2011. PMID: 21675909 No abstract available.

10

DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.

Chen M, Shabashvili D, Nawab A, Yang SX, Dyer LM, Brown KD, Hollingshead M, Hunter KW, Kaye FJ, Hochwald SN, Marquez VE, Steeg P, Zajac-Kaye M. Chen M, et al. Among authors: kaye fj. Mol Cancer Ther. 2012 Feb;11(2):370-82. doi: 10.1158/1535-7163.MCT-11-0458. Epub 2011 Dec 27. Mol Cancer Ther. 2012. PMID: 22203734 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters